Skip to content

Insider · CIK 0001993684

Jack Higgins

officer

Files at IMNM (Immunome Inc.). First filing Sep 15, 2026, latest Sep 15, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $334k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IMNM: Immunome Inc.

IMNMOct 9, 2026 · close 19.55

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
IMNMsell10b5-1
Immunome Inc.
$334k
13,200 shares
-17%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026IMNM
Immunome Inc.
MOption exercise
Common Stock10b5-1
+18,000$1.35$24k78,25027 d ago
Sep 11, 2026IMNM
Immunome Inc.
SOpen-market sale
Common Stock10b5-1
-13,200$25.32$334k65,05027 d ago
Sep 11, 2026IMNM
Immunome Inc.
GGift
Common Stock10b5-1
-8,800$0.00$056,25027 d ago
Sep 11, 2026IMNM
Immunome Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
+18,000$0.00$0133,84027 d ago
Mar 27, 2025IMNM
Immunome Inc.
MOption exercise
Common Stock
+5,200$1.35$7,02018,729Mar 28, 2025
Mar 27, 2025IMNM
Immunome Inc.
MOption exercise
Employee Stock option (right to buy)derivative
-5,200$0.00$0173,840Mar 28, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jack Higgins: insider trades and track record | InsiderTell